Previous studies have shown that miR-223-3p can specifically target the 3’UTR of NLRP3 and inhibit inflammatory reactions in inflammatory diseases such as rheumatoid arthritis, acute and chronic liver injury, tuberculosis [22, 27, 28]. Here, NLRP3 is linked to tuberculosis.